Groupe Bruxelles Lambert SA
69.00
CHF
+0.18
(+0.26%)
ISIN
BE0003797140
Return %
Stock
S&P 500
1Y
-2.39
14.20
3Y
-1.57
81.12
5Y
-33.73
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Quarterly Revenue
EUR
•
in mil. unless spec.Quarterly Earnings Per Share
EUR
•
in mil. unless spec.Quarterly Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Johannes Peter Huth
- Full Time Employees
- 5,207
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Avenue Marnix 24 Brussels BU Belgium 1000
- IPO Date
- Oct 15, 1956
- Website
- gbl.com
- Similar Companies
- Business
- Groupe Bruxelles Lambert S.A. (GBL) is a leading Belgian investment holding company focused on long-term value creation through a diversified portfolio of listed and private assets. Listed on Euronext Brussels since 1956 and headquartered in Brussels, GBL holds significant stakes in global companies including SGS (14.34%), Pernod Ricard (6.83%), adidas (3.53%), Imerys (54.72%), Umicore (15.92%), Concentrix (13.92%), Ontex (19.98%), GEA Group (0.07%) and TotalEnergies (0.01%); direct private assets encompass controlling stakes in healthcare providers Affidea (99.13%, advanced diagnostics and outpatient services across Europe) and Sanoptis (84.24%, ophthalmology services with operations in Switzerland, Germany, Spain, Italy, Austria and Greece), Canyon (51.31%, direct-to-consumer premium bicycles), plus minority stakes in Voodoo (14.99%, mobile game publishing) and Parques Reunidos (23.00%, European leisure parks); indirect private assets are managed via GBL Capital (funds, co-investments in firms like ICONIQ, Sagard and Backed); third-party asset management includes Sienna Investment Managers (pan-European strategies in listed equities, private equity, credit and venture capital). GBL operates primarily in Europe with additional exposure in North America and Asia-Pacific, targeting industrial, consumer goods, healthcare, digital and business services sectors. Recent developments include portfolio simplification through disposals such as partial SGS stake sale (€772m proceeds, Q1 2025), Umicore shares sale (completed 2025), €1.5bn from GBL Capital assets (announced November 2025, including transfers to Carlyle AlpInvest), and exclusive negotiations to sell Sienna Gestion and Sienna Private Credit to Malakoff Humanis (October 2025); value creation in direct privates with €584m uplift led by Affidea (+€478m, bolstered by €150m GBL equity injection October 2025) and Sanoptis (+€99m); enhanced shareholder returns via €5.00 dividend for FY2024 (+82%, yield 7.6%), ongoing share buybacks (€259m in 9M 2025) and total cash returns of €925m; GBL Capital ceased new commitments; net asset value stands at €14.0bn (€104.83/share) as of September 30, 2025, with liquidity of €4.8bn and LTV 1.8%.
Company News
CVC, Groupe Bruxelles Lambert Make $12.5 Billion Bid to Take Recordati Private
Groupe Bruxelles Lambert (OTCMKTS:GBLBY) Stock Price Down 5.3% – Should You Sell?
Umicore - Transparency notification by Groupe Bruxelles Lambert S.A.
Groupe Bruxelles: A Big 2025 Winner I Called And Missed
Groupe Bruxelles Lambert: The Ultimate Turnaround Play